Capital Flow Monitor · Sponsors · CIK 1786949
Sparrow Pharmaceuticals, Inc.
1050 Southwest 6th Street, PORTLAND, OR, 97204 · 6174650328
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$121.4M
Sold
$61.8M
% sold
50.9%
Investors
17
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-01 | D ·current | 506(b) | $121.4M | $61.8M | 50.9% | 17 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Robert Jacks — Executive Officer / Director, Portland, OR
-
Niall O'Donnell — Director, Portland, OR
1 other raise
- Allotera Therapeutics, Inc. $123.3M of $163.0M · 75.6%
-
Zach Scheiner — Director, Portland, OR
1 other raise
- Memento Medicines, Inc. $38.0M of $93.0M · 40.9%
-
Peter Thompson — Director, Portland, OR
2 other raises
- Alpheus Medical, Inc. $60.5M of $67.0M · 90.3%
- Terremoto Biosciences, Inc. $40.7M of $108.6M · 37.5%
-
Klaus Veitinger — Director, Portland, OR
1 other raise
- Alpheus Medical, Inc. $60.5M of $67.0M · 90.3%
- Nanna L?neborg — Director, Portland, OR
-
Jonathan Root — Director, Portland, OR
4 other raises
- Route 92 Medical, Inc. $50.0M of $50.0M · 100.0%
- Surgical Safety Technologies Inc. $18.2M of $20.2M · 90.1%
- AIS VGP-6, LLC $5.6M of $15.6M · 35.6%
- Okami Medical, Inc. $28.9M of $46.7M · 61.9%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.